Skip to main content
Clinical Trials/CTRI/2021/09/036371
CTRI/2021/09/036371
Not yet recruiting
Phase 4

A Clinical study to evaluate the Therapeutic effect of drug Tagaradi kwath in the management of Anidra (Insomnia)

Self0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition
Sponsor
Self
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Self

Eligibility Criteria

Inclusion Criteria

  • 1\)Patient of Anidra suffering upto 3 months of duration.
  • 2\)Nidranasha(Insomnia) according to Athens Insomnia Scale.
  • 3\)Patient without any complication of other disease will include in this study.

Exclusion Criteria

  • 1\)Anidra due to other conditions such as madatyaya,abhighata and othervsystemic diseases.
  • 2\)Patients on hypnotic medicine or other drugs known to cause drowsiness.
  • 3\)Patients with acute illness like myocardial infraction, congestive cardiac failure,COPD,meningitis,acute pain condition and similar other disease.
  • 4\)Patients with major psychiatric illness like epilepsy,schizophrenia,major depressive psychosis etc.
  • 5\)Patients having chronic disease like liver cirrhosis,asthma,malignancies,diabetes,hypertension and chronic renal failure

Outcomes

Primary Outcomes

Not specified

Similar Trials